About David Esposito
Form D filings for ONL Therapeutics from 2019 to 2024 list David Esposito as CEO & President, director.
David Esposito first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name David Esposito in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Esposito works with at each company, as listed on that company's latest Form D.
ONL Therapeutics, Inc. · Form D, Sep 16, 2024
CC
Constance Chang
Executive officer
AF
Aaron Fletcher
Director
MS
Michal Silverberg
Director
BB
Bill Burns
Director
DZ
David Zacks
Executive officer
MN
Marian Nakada
Director